Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL521318 | 0.86 | PDE9A (0.31) | — | |
| Vinyl Ether SCHEMBL13836190 | 0.80 | EPHX1 (0.41) | EPHX1 | |
| SCHEMBL9903979 | 0.78 | PDE9A (0.41) | — | |
| SCHEMBL16689100 | 0.78 | EPHX1 (0.30) | EPHX1 | |
| SCHEMBL363775 | 0.78 | TSHR (0.33) | EPHX1 | |
| SCHEMBL9839303 | 0.77 | — | — | |
| SCHEMBL77233 | 0.77 | NUDT1 (0.30) | — | |
| SCHEMBL1856794 | 0.77 | NUDT1 (0.30) | — | |
| SCHEMBL1533016 | 0.73 | — | — | |
| SCHEMBL521656 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8975349-B2 | Cationically polymerizable resin composition and cured object obtained therefrom | DAICEL CORPORATION (JP) | 2015-03-10 | — | — | US | disclosed |
| EP-2441761-A1 | Oxetane-containing vinyl ether compounds and polymerizable compositions | Daicel Chemical Industries, Ltd. (JP) | 2012-04-18 | — | — | EP | disclosed |
| US-20120077946-A1 | CATIONICALLY POLYMERIZABLE RESIN COMPOSITION AND CURED OBJECT OBTAINED THEREFROM | DAICEL CORPORATION (JP) | 2012-03-29 | — | — | US | disclosed |
| US-20120027342-A1 | CATION-POLYMERIZABLE RESIN COMPOSITION AND CURED PRODUCT THEREOF | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2012-02-02 | — | — | US | disclosed |
| US-7985866-B2 | Oxetane-containing vinyl ether compound | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2011-07-26 | — | — | US | disclosed |
| EP-2233475-A1 | Epoxycyclohexane vinyl ether compounds and their use in polymerizable compositions | Daicel Chemical Industries, Ltd. (JP) | 2010-09-29 | — | — | EP | disclosed |
| US-20080234455-A1 | Vinyl ether compounds and polymerizable compositions | DAICEL CHEMICAL INDUSTRIES, LTD. | 2008-09-25 | — | — | US | disclosed |
| EP-1972622-A2 | Vinyl ether compounds and polymerizable compositions | Daicel Chemical Industries, Ltd. (JP) | 2008-09-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234455-A1 | Vinyl ether compounds and polymerizable compositions | CBR1, ECH1, VDAC1 | EPHX1 344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.